M. Ackermann and R. Padmanabhan, De Novo Synthesis of RNA by the Dengue Virus RNA-dependent RNA Polymerase Exhibits Temperature Dependence at the Initiation but Not Elongation Phase, Journal of Biological Chemistry, vol.276, issue.43, pp.39926-39937, 2001.
DOI : 10.1074/jbc.M104248200

S. S. Alkan, Landmark: Monoclonal antibodies: the story of a discovery that revolutionized science and medicine, Nature Reviews Immunology, vol.6, issue.2, pp.153-156, 2004.
DOI : 10.1038/nrd984

Z. An, Monoclonal antibodies ??? a proven and rapidly expanding therapeutic modality for human diseases, Protein & Cell, vol.23, issue.4, pp.319-330, 2010.
DOI : 10.1007/s13238-010-0052-8

M. Beltramello and K. L. Williams, The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity, Cell Host & Microbe, vol.8, issue.3, pp.271-283, 2010.
DOI : 10.1016/j.chom.2010.08.007

URL : https://hal.archives-ouvertes.fr/pasteur-00530282

G. L. Boulianne and N. Hozumi, Production of functional chimaeric mouse/human antibody, Nature, vol.103, issue.5995, pp.643-646, 1984.
DOI : 10.1038/312643a0

D. Bourel and J. L. Teillaud, Anticorps monoclonaux : tours et d??tours technologiques pour de nouveaux espoirs th??rapeutiques, Comptes Rendus Biologies, vol.329, issue.4, pp.217-227, 2006.
DOI : 10.1016/j.crvi.2006.02.006

O. H. Brekke and I. Sandlie, Therapeutic antibodies for human diseases at the dawn of the twenty-first century, Nature Reviews Drug Discovery, vol.2, issue.1, pp.52-62, 2003.
DOI : 10.1038/nrd984

J. D. Brien and S. K. Austin, Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3, Journal of Virology, vol.84, issue.20, pp.10630-10643, 2010.
DOI : 10.1128/JVI.01190-10

A. Casadevall and E. Dadachova, Passive antibody therapy for infectious diseases, Nature Reviews Microbiology, vol.25, issue.9, pp.695-703, 2004.
DOI : 10.1056/NEJM199311183292102

M. C. Cassetti and A. Durbin, Report of an NIAID workshop on dengue animal models, Vaccine, vol.28, issue.26, pp.4229-4234, 2010.
DOI : 10.1016/j.vaccine.2010.04.045

K. Chen and W. Xu, Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell???stimulating programs in basophils, Nature Immunology, vol.152, issue.8, pp.889-898, 2009.
DOI : 10.1038/ni.1748

J. I. Cohen and F. Wang, Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation., Proceedings of the National Academy of Sciences, vol.86, issue.23, pp.9558-9562, 1989.
DOI : 10.1073/pnas.86.23.9558

H. J. Delecluse and T. Hilsendegen, Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells, Proceedings of the National Academy of Sciences, vol.95, issue.14, pp.95-8245, 1998.
DOI : 10.1073/pnas.95.14.8245

C. Desgranges, Anticorps monoclonaux et th??rapeutique, Pathologie Biologie, vol.52, issue.6, pp.351-364, 2004.
DOI : 10.1016/j.patbio.2003.09.017

M. Diaz and J. Daly, Immunology: B cells break the rules, Nature, vol.135, issue.7252, pp.184-186, 2009.
DOI : 10.1038/460184a

M. P. Egloff and D. Benarroch, An RNA cap (nucleoside-2'-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization, The EMBO Journal, vol.21, issue.11, pp.2757-2768, 2002.
DOI : 10.1093/emboj/21.11.2757

R. Ettinger and G. P. Sims, IL-21 Induces Differentiation of Human Naive and Memory B Cells into Antibody-Secreting Plasma Cells, The Journal of Immunology, vol.175, issue.12, pp.7867-7879, 2005.
DOI : 10.4049/jimmunol.175.12.7867

B. Falgout and R. H. Miller, Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity, J Virol, vol.67, issue.4, pp.2034-2042, 1993.

B. Falgout and M. Pethel, Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins, J Virol, vol.65, issue.5, pp.2467-2475, 1991.

N. Fischer and O. Leger, Bispecific Antibodies: Molecules That Enable Novel Therapeutic Strategies, Pathobiology, vol.74, issue.1, pp.3-14, 2007.
DOI : 10.1159/000101046

J. Fraussen and K. Vrolix, A novel method for making human monoclonal antibodies, Journal of Autoimmunity, vol.35, issue.2, pp.130-134, 2010.
DOI : 10.1016/j.jaut.2010.05.001

A. Funaro and G. Gribaudo, Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells, BMC Biotechnology, vol.8, issue.1, p.85, 2008.
DOI : 10.1186/1472-6750-8-85

R. V. Gibbons, Dengue conundrums, International Journal of Antimicrobial Agents, vol.36, 2010.
DOI : 10.1016/j.ijantimicag.2010.06.019

R. V. Gibbons, Dengue conundrums, International Journal of Antimicrobial Agents, vol.36, issue.1, pp.36-39, 2010.
DOI : 10.1016/j.ijantimicag.2010.06.019

K. L. Good and V. L. Bryant, Kinetics of Human B Cell Behavior and Amplification of Proliferative Responses following Stimulation with IL-21, The Journal of Immunology, vol.177, issue.8, pp.5236-5247, 2006.
DOI : 10.4049/jimmunol.177.8.5236

L. L. Green and M. C. Hardy, Antigen???specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs, Nature Genetics, vol.1, issue.1, pp.13-21, 1994.
DOI : 10.1016/0092-8674(81)90400-1

N. Green and R. D. Ott, Cell-based assays to identify inhibitors of viral disease, Expert Opinion on Drug Discovery, vol.56, issue.6, pp.671-676, 2008.
DOI : 10.1021/bi0621415

B. Guy and M. Saville, Development of sanofi pasteur tetravalent dengue vaccine, Human Vaccines, vol.6, issue.9, 2010.
DOI : 10.4161/hv.6.9.12739

M. G. Guzman and S. B. Halstead, Dengue: a continuing global threat, Nature Reviews Microbiology, vol.11, issue.12, pp.7-16, 2010.
DOI : 10.1038/nrmicro2460

W. Hammerschmidt, What keeps the power on in lymphomas?, Blood, vol.117, issue.6, pp.1777-1778, 2011.
DOI : 10.1182/blood-2010-12-322222

W. Hammerschmidt and B. Sugden, Genetic analysis of immortalizing functions of Epstein???Barr virus in human B lymphocytes, Nature, vol.340, issue.6232, pp.393-397, 1989.
DOI : 10.1038/340393a0

W. M. Hammon and A. Rudnick, Viruses Associated with Epidemic Hemorrhagic Fevers of the Philippines and Thailand, Science, vol.131, issue.3407, pp.1102-1103, 1960.
DOI : 10.1126/science.131.3407.1102

J. Hanna and S. Markoulaki, Direct Reprogramming of Terminally Differentiated Mature B Lymphocytes to Pluripotency, Cell, vol.133, issue.2, pp.250-264, 2008.
DOI : 10.1016/j.cell.2008.03.028

H. R. Hoogenboom, Overview of Antibody Phage-Display Technology and Its Applications, Methods Mol Biol, vol.178, pp.1-37, 2002.
DOI : 10.1385/1-59259-240-6:001

H. P. Hu and S. C. Hsieh, Characterization of retrovirus-based reporter viruses pseudotyped with the precursor membrane and envelope glycoproteins of four serotypes of dengue viruses, Virology, vol.368, issue.2, pp.376-387, 2007.
DOI : 10.1016/j.virol.2007.06.026

P. J. Hudson and C. Souriau, Engineered antibodies, Nature Medicine, vol.168, issue.1, pp.129-134, 2003.
DOI : 10.1038/nm0302-295

A. Ichikawa and Y. Katakura, In vitro immunization of human peripheral blood lymphocytes: establishment of B cell lines secreting IgM specific for cholera toxin B subunit from lymphocytes stimulated with IL-2 and IL-4, Cytotechnology, vol.31, issue.1/2, pp.133-141, 1999.
DOI : 10.1023/A:1008063903946

C. C. Jansen and N. W. Beebe, The dengue vector Aedes aegypti: what comes next, Microbes and Infection, vol.12, issue.4, pp.272-279, 2010.
DOI : 10.1016/j.micinf.2009.12.011

B. W. Johnson and B. J. Russell, Serotype-Specific Detection of Dengue Viruses in a Fourplex Real-Time Reverse Transcriptase PCR Assay, Journal of Clinical Microbiology, vol.43, issue.10, pp.4977-4983, 2005.
DOI : 10.1128/JCM.43.10.4977-4983.2005

P. T. Jones and P. H. Dear, Replacing the complementarity-determining regions in a human antibody with those from a mouse, Nature, vol.312, issue.6069, pp.522-525, 1986.
DOI : 10.1038/321522a0

C. Kaiser and G. Laux, The proto-oncogene c-myc is a direct target gene of Epstein- Barr virus nuclear antigen 2, J Virol, vol.73, issue.5, pp.4481-4484, 1999.

K. M. Kaye and K. M. Izumi, Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation., Proceedings of the National Academy of Sciences, vol.90, issue.19, pp.90-9150, 1993.
DOI : 10.1073/pnas.90.19.9150

Z. Y. Keck and T. K. Li, Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies, Journal of Virology, vol.82, issue.12, pp.6061-6066, 2008.
DOI : 10.1128/JVI.02475-07

B. Kempkes and D. Pich, Immortalization of human B lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA, J Virol, vol.69, issue.1, pp.231-238, 1995.

B. Kempkes and D. Spitkovsky, B-cell proliferation and induction of early G1- regulating proteins by Epstein-Barr virus mutants conditional for EBNA2, EMBO J, vol.14, issue.1, pp.88-96, 1995.

E. Kilger and A. Kieser, Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1,which simulates an activated CD40 receptor, The EMBO Journal, vol.17, issue.6, pp.1700-1709, 1998.
DOI : 10.1093/emboj/17.6.1700

G. Kohler and C. Milstein, Continuous cultures of fused cells secreting antibody of predefined specificity, Nature, vol.3, issue.5517, pp.495-497, 1975.
DOI : 10.1038/256495a0

M. J. Kwakkenbos and S. A. Diehl, Generation of stable monoclonal antibody???producing B cell receptor???positive human memory B cells by genetic programming, Nature Medicine, vol.79, issue.1, pp.123-128, 2010.
DOI : 10.1038/nm.2071

R. S. Lanciotti and C. H. Calisher, Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction, J Clin Microbiol, vol.30, issue.3, pp.545-551, 1992.

A. Lanzavecchia and D. Corti, Human monoclonal antibodies by immortalization of memory B cells, Current Opinion in Biotechnology, vol.18, issue.6, pp.523-528, 2007.
DOI : 10.1016/j.copbio.2007.10.011

J. M. Lee and K. H. Lee, EBNA2 Is Required for Protection of Latently Epstein-Barr Virus-Infected B Cells against Specific Apoptotic Stimuli, Journal of Virology, vol.78, issue.22, pp.12694-12697, 2004.
DOI : 10.1128/JVI.78.22.12694-12697.2004

J. M. Lee and K. H. Lee, Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis, Proceedings of the National Academy of Sciences, vol.99, issue.18, pp.11878-11883, 2002.
DOI : 10.1073/pnas.182552499

R. Levy and J. Dilley, Rescue of immunoglobulin secretion from human neoplastic lymphoid cells by somatic cell hybridization., Proceedings of the National Academy of Sciences, vol.75, issue.5, pp.2411-2415, 1978.
DOI : 10.1073/pnas.75.5.2411

B. D. Lindenbach and C. M. Rice, trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication, J Virol, vol.71, issue.12, pp.9608-9617, 1997.

N. Lonberg, Human Monoclonal Antibodies from Transgenic Mice, Handb Exp Pharmacol, issue.181, pp.69-97, 2008.
DOI : 10.1007/978-3-540-73259-4_4

N. Lonberg and L. D. Taylor, Antigen-specific human antibodies from mice comprising four distinct genetic modifications, Nature, vol.368, issue.6474, pp.856-859, 1994.
DOI : 10.1038/368856a0

J. S. Mackenzie and D. J. Gubler, Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses, Nature Medicine, vol.59, issue.12s, pp.98-109, 2004.
DOI : 10.1016/S1473-3099(01)00016-0

A. J. Macpherson and K. D. Mccoy, The immune geography of IgA induction and function, Mucosal Immunology, vol.338, issue.1, pp.11-22, 2008.
DOI : 10.1038/mi.2007.6

J. B. Mannick and J. I. Cohen, The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation, J Virol, vol.65, issue.12, pp.6826-6837, 1991.

T. Matsumoto and K. Yamada, Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus, Microbiology and Immunology, vol.115, issue.11, pp.673-683, 2010.
DOI : 10.1111/j.1348-0421.2010.00262.x

J. Mccafferty and A. D. Griffiths, Phage antibodies: filamentous phage displaying antibody variable domains, Nature, vol.348, issue.6301, pp.552-554, 1990.
DOI : 10.1038/348552a0

S. Miller and S. Kastner, The Non-structural Protein 4A of Dengue Virus Is an Integral Membrane Protein Inducing Membrane Alterations in a 2K-regulated Manner, Journal of Biological Chemistry, vol.282, issue.12, pp.8873-8882, 2007.
DOI : 10.1074/jbc.M609919200

S. Miller and S. Sparacio, Subcellular Localization and Membrane Topology of the Dengue Virus Type 2 Non-structural Protein 4B, Journal of Biological Chemistry, vol.281, issue.13, pp.8854-8863, 2006.
DOI : 10.1074/jbc.M512697200

S. L. Morrison and M. J. Johnson, Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains., Proceedings of the National Academy of Sciences, vol.81, issue.21, pp.81-6851, 1984.
DOI : 10.1073/pnas.81.21.6851

C. Y. Ng and F. Gu, Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing, Antiviral Research, vol.76, issue.3, pp.222-231, 2007.
DOI : 10.1016/j.antiviral.2007.06.007

C. G. Noble and Y. L. Chen, Strategies for development of dengue virus inhibitors, Antiviral Research, vol.85, issue.3, pp.450-462, 2010.
DOI : 10.1016/j.antiviral.2009.12.011

L. Olsson and H. S. Kaplan, Human-human hybridomas producing monoclonal antibodies of predefined antigenic specificity., Proceedings of the National Academy of Sciences, vol.77, issue.9, pp.5429-5431, 1980.
DOI : 10.1073/pnas.77.9.5429

X. Pang and M. Zhang, Development of Dengue virus type 2 replicons capable of prolonged expression in host cells, BMC Microbiology, vol.1, issue.1, p.18, 2001.
DOI : 10.1186/1471-2180-1-18

G. Pontecorvo, Production of mammalian somatic cell hybrids by means of polyethylene glycol treatment, Somatic Cell Genetics, vol.255, issue.4, pp.397-400, 1975.
DOI : 10.1007/BF01538671

Y. Qu and L. Ramachandra, P2X7 Receptor-Stimulated Secretion of MHC Class II-Containing Exosomes Requires the ASC/NLRP3 Inflammasome but Is Independent of Caspase-1, The Journal of Immunology, vol.182, issue.8, pp.5052-5062, 2009.
DOI : 10.4049/jimmunol.0802968

D. Ray and A. Shah, West Nile Virus 5'-Cap Structure Is Formed by Sequential Guanine N-7 and Ribose 2'-O Methylations by Nonstructural Protein 5, Journal of Virology, vol.80, issue.17, pp.8362-8370, 2006.
DOI : 10.1128/JVI.00814-06

F. A. Rey and F. X. Heinz, The envelope glycoprotein from tick-borne encephalitis virus at 2 ?? resolution, Nature, vol.375, issue.6529, pp.291-298, 1995.
DOI : 10.1038/375291a0

L. Riechmann and M. Clark, Reshaping human antibodies for therapy, Nature, vol.332, issue.6162, pp.323-327, 1988.
DOI : 10.1038/332323a0

I. A. Rodenhuis-zybert and J. Wilschut, Dengue virus life cycle: viral and host factors modulating infectivity, Cellular and Molecular Life Sciences, vol.11, issue.Pt 2, pp.2773-2786, 2010.
DOI : 10.1007/s00018-010-0357-z

A. B. Sabin and R. W. Schlesinger, PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE, Science, vol.101, issue.2634, pp.640-642, 1945.
DOI : 10.1126/science.101.2634.640

F. Sallusto and A. Lanzavecchia, From Vaccines to Memory and Back, Immunity, vol.33, issue.4, pp.451-463, 2010.
DOI : 10.1016/j.immuni.2010.10.008

J. S. Schieffelin and J. M. Costin, Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient, Virology Journal, vol.7, issue.1, p.28, 2010.
DOI : 10.1186/1743-422X-7-28

A. C. Schmidt, Response to Dengue Fever ??? The Good, the Bad, and the Ugly?, New England Journal of Medicine, vol.363, issue.5, pp.484-487, 2010.
DOI : 10.1056/NEJMcibr1005904

D. Schrama and R. A. Reisfeld, Antibody targeted drugs as cancer therapeutics, Nature Reviews Drug Discovery, vol.87, issue.2, pp.147-159, 2006.
DOI : 10.1038/nrd1957

S. Siberil and C. A. Dutertre, Anticorps monoclonaux ?? usage th??rapeutique??: un peu d'histoire, beaucoup d'ing??nierie, et ??? quelques succ??s cliniques, Transfusion Clinique et Biologique, vol.12, issue.2, pp.114-122, 2005.
DOI : 10.1016/j.tracli.2005.04.016

C. P. Simmons and N. L. Bernasconi, Prophylactic and Therapeutic Efficacy of Human Monoclonal Antibodies against H5N1 Influenza, PLoS Medicine, vol.8, issue.5, p.178, 2007.
DOI : 10.1371/journal.pmed.0040178.t002

M. Steinitz and G. Klein, EB virus-induced B lymphocyte cell lines producing specific antibody, Nature, vol.10, issue.5627, pp.420-422, 1977.
DOI : 10.1016/0019-2791(75)90184-6

S. Sukupolvi-petty and S. K. Austin, Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2, Journal of Virology, vol.84, issue.18, pp.9227-9239, 2010.
DOI : 10.1128/JVI.01087-10

K. Takahashi and S. Yamanaka, Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors, Cell, vol.126, issue.4, pp.663-676, 2006.
DOI : 10.1016/j.cell.2006.07.024

B. H. Tan and J. Fu, Recombinant Dengue Type 1 Virus NS5 Protein Expressed inEscherichia coliExhibits RNA-Dependent RNA Polymerase Activity, Virology, vol.216, issue.2, pp.317-325, 1996.
DOI : 10.1006/viro.1996.0067

R. Teyssou, [Dengue fever: from disease to vaccination], Med Trop (Mars), vol.69, issue.4, pp.333-334, 2009.

K. Tomizuka and H. Yoshida, Functional expression and germline atransmission of a human chromosome fragment in chimaeric mice, Nature Genetics, vol.23, issue.2, pp.133-143, 1997.
DOI : 10.1006/bbrc.1995.2107

B. Tomkinson and E. Kieff, Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection, J Virol, vol.66, issue.2, pp.780-789, 1992.

B. Tomkinson and E. Kieff, Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro, J Virol, vol.66, issue.5, pp.2893-2903, 1992.

S. Tonegawa, Somatic generation of antibody diversity, Nature, vol.26, issue.5909, pp.575-581, 1983.
DOI : 10.1038/302575a0

E. Traggiai and S. Becker, An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus, Nature Medicine, vol.162, issue.8, pp.871-875, 2004.
DOI : 10.1128/JVI.77.19.10394-10403.2003

M. Verhoeyen and C. Milstein, Reshaping human antibodies: grafting an antilysozyme activity, Science, vol.239, issue.4847, pp.1534-1536, 1988.
DOI : 10.1126/science.2451287

L. Waltzer and F. Logeat, The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements, EMBO J, vol.13, issue.23, pp.5633-5638, 1994.

W. Wang and E. Q. Wang, Monoclonal Antibody Pharmacokinetics and Pharmacodynamics, Clinical Pharmacology & Therapeutics, vol.38, issue.5, pp.548-558, 2008.
DOI : 10.1007/s00280-005-1022-3

G. Wengler, The carboxy-terminal part of the NS 3 protein of the West Nile Flavivirus can be isolated as a soluble protein after proteolytic cleavage and represents an RNA-stimulated NTPase, Virology, vol.184, issue.2, pp.707-715, 1991.
DOI : 10.1016/0042-6822(91)90440-M

G. Wengler, The NS 3 Nonstructural Protein of Flaviviruses Contains an RNA Triphosphatase Activity, Virology, vol.197, issue.1, pp.265-273, 1993.
DOI : 10.1006/viro.1993.1587

S. S. Whitehead and J. E. Blaney, Prospects for a dengue virus vaccine, Nature Reviews Microbiology, vol.193, issue.7, pp.518-528, 2007.
DOI : 10.1038/nrmicro1690

Y. Wu and J. Xu, Rapid induction of a novel costimulatory activity on B cells by CD40 ligand, Current Biology, vol.5, issue.11, pp.1303-1311, 1995.
DOI : 10.1016/S0960-9822(95)00257-0

J. L. Yates and N. Warren, Stable replication of plasmids derived from Epstein???Barr virus in various mammalian cells, Nature, vol.26, issue.6005, pp.812-815, 1985.
DOI : 10.1038/313812a0

Z. Yin and Y. L. Chen, An adenosine nucleoside inhibitor of dengue virus, Proceedings of the National Academy of Sciences, vol.106, issue.48, pp.20435-20439, 2009.
DOI : 10.1073/pnas.0907010106

Y. L. Yip and C. M. Tsang, Expression of Epstein-Barr virus-encoded LMP1 and hTERT extends the life span and immortalizes primary cultures of nasopharyngeal epithelial cells, Journal of Medical Virology, vol.30, issue.10, pp.1711-1723, 2010.
DOI : 10.1002/jmv.21875